BRAF and early-onset autosomal dominant Alzheimer disease: Mbns also show great potential in the treatment of copper-associated illnesses such as Wilson disease (WD), Alzheimer disease (AD), fatty liver disease, and BRAF-positive cancers by preventing copper buildup in the liver and consequently other body tissues, and thereby preventing permanent liver and neurological tissue damage [83].